Schwartz ME: Liver transplantation for hepatocellular carcinoma: the best treatment, but for which patient ? Hepatology 1996, 24 :1539–1541.ch wartz ME.Liver transplantation for hepatocellular carcinoma:The best treatment ,but for which patient?. Hematological Oncology . 1996...
Locoregional treatment for hepatocellular carcinoma: The best is yet to come. World J Radiol 2015; 7 : 306-18.KALRA N, GUPTA P, CHAWLA Y, et al. Locoregional treat- ment for hepatocellular carcinoma: The best is yet to come [J]. World J Radiol, 2015, 7(10): 306-318.Kalra N, ...
Hepatocellular Carcinoma Recurrence: How to Manage Duilio Pagano, Giuseppe Mamone, Ioannis Petridis, and Salvatore Gruttadauria 23 23.1 Introduction Liver resection (LR) and transplantation (LT) are curative surgical options for patients with hepatocellular carcinoma (HCC). The latter, ...
The last 3 years have seen the emergence of promising targeted therapies for the treatment of hepatocellular carcinoma (HCC). Sorafenib has been the mainstay of treatment for a decade and newer modalities were ineffective and did not confer any increased therapeutic benefit until the introduction of...
Hepatocellular carcinoma (HCC) is a common type of tumor worldwide. The development of systemic treatment of advanced HCC has remained stagnant for a considerable period. During the last years, a series of new treatment regimens based on the combination of immunotherapeutic drugs and targeted drugs...
Treatment of Hepatocellular Carcinoma Associated with Cirrhosis in the Era of Liver Transplantation. Reviews the treatment of cirrhotic patients with hepatocellular carcinoma in the era of liver transplantation to find out the best way to treat patients at... Mor,Eytan,Kaspa,... - 《Annals of Int...
Hepatocellular carcinoma (HCC) is a common cause of cancer-related death, with incidence increasing worldwide. Unfortunately, the overall prognosis for patients with HCC is poor and many patients present with advanced stages of disease that preclude cura
Hepatocellular carcinoma (HCC) is the fourth most lethal type of malignancies worldwide and effective treatment for advanced HCC is currently lacking8. Exhaustion of infiltrating T cells has been convincingly observed in HCC, and has been linked to poor clinical outcome9. However, what induces T-...
篇名 Locoregional treatment for hepatocellular carcinoma:The best is yet to come 来源期刊 世界放射学杂志:英文版(电子版) 学科 医学 关键词 HEPATOCELLULAR carcinoma High INTENSITY focussed u 年,卷(期) 2015,(10) 所属期刊栏目 研究方向 页码范围 306-318 页数 13页 分类号 R735.7 字数 语种 DOI ...
Hepatocellular carcinoma (HCC) is one of the most common and lethal malignant tumors in the world. Therapeutic options for advanced HCC are limited. Systemic treatment, especially with conventional cytotoxic drugs, is usually ineffective. For more than a